← Back to catalogue

OEM 81-13 Drug Test

FDA UDI

Class II (US FDA UDI)

by Ucp Biosciences, Inc.

Identity

Trade Name
OEM 81-13 Drug Test FDA UDI
Generic Name
Amphetamine/methamphetamine group IVD, kit, rapid ICT, clinical FDA UDI
Device Name
OEM 81-13 Drug Test 3 Panel Dip Card AMP/COC/THC FDA UDI
Model / Reference
U-DOA-134 FDA UDI
Description
OEM 81-13 Drug Test 3 Panel Dip Card AMP/COC/THC FDA UDI

Identifiers

Catalog Number
U-DOA-134 FDA UDI
Primary DI / UDI-DI
10817038022129 FDA UDI
510(k) Number
K131811 FDA UDI
FDA Product Code
DKZ FDA UDI
DIO FDA UDI
LDJ FDA UDI
GMDN Term
Amphetamine/methamphetamine group IVD, kit, rapid ICT, clinical FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
862.3100 FDA UDI
862.3250 FDA UDI
862.3870 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

Yes

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Cannabinoid/cannabinoid metabolite IVD, kit, rapid ICT, clinicalCocaine/cocaine metabolite IVD, kit, rapid ICT, clinicalAmphetamine/methamphetamine group IVD, kit, rapid ICT, clinical

OEM 81-13 Drug Test by Ucp Biosciences, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Amphetamine/methamphetamine group IVD, kit, rapid ICT, clinical.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI e9b545c4-ef04-420c-9fec-9331dc428bf7 37 fields · synced Jun 8, 2026